Can-Fite BioPharma Ltd. Payments to Acquire Other Investments
Can-Fite BioPharma Ltd. (CANF) reported Payments to Acquire Other Investments of $14.50 million for the 12-month period ending 2021-12-31, per its 20-F filed 2022-03-24.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireOtherInvestments · last filed 2022-03-24
| Period end | Payments to Acquire Other Investments 12 month |
|---|---|
| 2021-12-31 | $14.50M 20-F · filed 2022-03-24 |